Penn Medicine 2020 Updates in Oncology
Video Player is loading.
10 seconds
Playback speed
2020 Adjuvant Escalation and De-escalation in Early Stage BC: Is T-DM1/Pt Superior to THP for High-risk HER2+ Disease? 1 Year of Capecitabine vs. Observation in High-risk TNBC - Which Option Is Superior? Is There a Benefit to Anthracycline in HER2+ Disease?
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Angela DeMichele
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Angela DeMichele
Comments 1
Login to view comments.
Click here to Login
